Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Satoshi Osawa has a total of 295 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ectopic gastric squamous metaplasia with concomitant well-differentiated adenocarcinoma: a case report

    by Kenichi Takahashi, Satoshi Osawa, Rei Ishikawa, Ryoji Kushima, Yusuke Asai, Natsuki Ishida, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Takanori Yamada, et al.

    Gastric squamous metaplasia is a rare condition whose clinical significance and malignant potential remain unclear. Most reported cases are located in the

  • Open Access

    Effect of Low-Dose Vonoprazan on Hepatic Cytochrome P450 Activity By 13C-Aminopyrine Breath Test in Healthy Subjects

    by Satoru Takahashi, Mihoko Yamade, Takahisa Furuta, Tomohiro Higuchi, Mikihiro Shimizu, Keisuke Inagaki, Kiichi Sugiura, Tomoharu Matsuura, Natsuki Ishida, Takanori Yamada, et al.

    Effect of Low-Dose Vonoprazan on Hepatic Cytochrome P450 Activity By 13C-Aminopyrine Breath Test in Healthy Subjects - Article abstract #953332

  • Open Access

    Endoscopic Diagnosis of Necator americanus Infection Presenting With Persistent Iron‐Deficiency Anemia: Usefulness of Image‐Enhanced Endoscopy and Capsule Endoscopy

    by Tomohiro Takebe, Satoshi Osawa, Yukihiro Watanabe, Shingo Yamagata, Takuya Aoyama, Yusuke Kawamura, Airi Manabe, Taro Kisamori, Munetaka Sano, Ken Sugimoto

    Necator americanus infection is now rare in developed countries but remains an important cause of iron‐deficiency anemia and abdominal symptoms in individuals with relevant epidemiological backgrounds. A 59‐year‐old Filipino man with long‐standing unexplained iron‐deficiency anemia was admitted to our hospital for epigastric pain associated with choledocholithiasis. Although biliary enzymes improved after endoscopic treatment, his abdominal pain persisted. Subsequent gastrointestinal investigations, including upper gastrointestinal endoscopy, colonoscopy, and small‐bowel capsule endoscopy, revealed multiple parasites distributed throughout the gastrointestinal tract. Image‐enhanced endoscopy using narrow‐band imaging clearly improved visualization of the parasites compared with conventional white‐light imaging, facilitating their identification and endoscopic removal. Genetic analysis of the extracted worms confirmed N. americanus infection. The patient was treated with pyrantel pamoate, which resulted in the resolution of abdominal symptoms and improvement of iron‐deficiency anemia. Follow‐up stool examination confirmed eradication of the parasite. This case highlights the importance of considering hookworm infection in patients with persistent iron‐deficiency anemia and abdominal pain, even in developed countries. In addition, image‐enhanced endoscopy and capsule endoscopy are valuable diagnostic tools for detecting hookworms and assessing their distribution within the gastrointestinal tract.

  • Open Access

    A Prospective Study Comparing the Diagnostic Ability of Abdominal Ultrasonography with Computed Tomography in Cases Suspected of Retaining the Patency Capsule

    by Tomoharu Matsuura, Satoshi Osawa, Moriya Iwaizumi, Ryota Inoue, Wataru Inui, Tomoyuki Niwa, Kenichi Takahashi, Takatoshi Egami, Keisuke Inagaki, Tomohiro Takebe, et al.

    Objectives: Patency capsule (PC) testing is widely used to assess small‐bowel patency before small‐bowel capsule endoscopy (SBCE). Although abdominal computed tomography (CT) reliably identifies PC location, routine use is limited by radiation exposure and cost. Abdominal ultrasonography (AUS) is a noninvasive, radiation‐free alternative; however, its diagnostic accuracy for PC localization remains unclear. Methods: We conducted a prospective, exploratory, single‐center study in patients in whom PC excretion could not be confirmed within the predefined observation period. All patients underwent AUS followed by CT on the same day. The primary endpoint was the sensitivity of AUS for detecting small‐bowel PC retention using CT as the reference standard. Secondary endpoints included the PC visualization rate, diagnostic accuracy for small bowel versus colon classification, six‐segment agreement between AUS and CT, and SBCE retention after AUS‐based assessment. Results: Thirty‐four patients were included. AUS visualized the PC in 28 patients (82.4%). All six patients with small‐bowel retention on CT were correctly identified as “small bowel” by AUS (sensitivity 100%; 95% confidence interval [CI], 61.0–100). Among 28 patients with colonic PC on CT, AUS classified 22 as “colon,” yielding a sensitivity of 78.6% (95% CI, 60.5–89.9). Six‐segment agreement between AUS and CT was 82.4% overall and 100% among visualized cases. No SBCE retention occurred after AUS‐based colonic classification. Conclusions: AUS accurately detected small‐bowel PC retention and showed good agreement with CT when visualization was achieved. Although non‐visualized findings require cautious interpretation, AUS may serve as a useful first‐line imaging modality for evaluating PC location prior to SBCE. Trial Registration: N/A.


  • Open Access

    Real-World Evaluation of an AI-Assisted Diagnostic Support System for Early Gastric Cancer: Diagnostic Performance, Confidence Stratification, and Determinants of False-Positive Diagnosis

    by Satoshi Osawa, Takanori Yamada, Wataru Inui, Tomoyuki Niwa, Kenichi Takahashi, Takatoshi Egami, Keisuke Inagaki, Tomohiro Takebe, Tatsuhiro Ito, Satoru Takahashi, et al.

    Background/Objectives: Artificial intelligence (AI)-assisted endoscopy has shown high sensitivity for early gastric cancer detection; however, false-positive diagnoses remain a clinical challenge. This study aimed to evaluate the real-world diagnostic performance of a commercially available AI system and to identify factors associated with false-positive diagnoses, focusing on repeated AI evaluations and confidence stratification. Methods: This single-center retrospective study included 47 patients with 89 localized gastric lesions evaluated between March 2024 and March 2025. Endoscopic examinations were performed under white-light, non-magnified observation with repeated AI assessments of each lesion. The rates of “Consider biopsy” (B) judgments were calculated. Lesions with a B judgment rate of ≥50% were defined as AI-positive and classified into four AI confidence categories. Diagnostic performance was assessed using sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Factors associated with false-positive diagnoses were analyzed using penalized logistic regression. Results: The AI system demonstrated a sensitivity of 97.6% and an NPV of 95.7%, with a specificity of 45.8%. Pathology-positive rates decreased stepwise across the four AI confidence categories (p < 0.001). Among AI-positive lesions, low regional reproducibility, lesion size ≥ 30 mm, scar, and erosion were independently associated with false-positive diagnoses. In analyses restricted to non-neoplastic lesions, lesion size ≥ 30 mm remained significantly associated with false-positive diagnosis. Conclusions: In real-world clinical practice, a commercially available AI system provides high sensitivity for early gastric cancer detection. Incorporating confidence stratification and regional reproducibility into clinical decision-making may enhance the effective use of AI-assisted endoscopic diagnosis beyond binary interpretations.


  • Open Access

    Immunohistochemical and molecular evolutionary features of jejunoileal adenocarcinoma unveiled through comparative analysis with colorectal adenocarcinoma

    by Rei Ishikawa, Hidetaka Yamada, Hirotomo Saitsu, Ryosuke Miyazaki, Juri Takahashi, Rino Takinami, Satoshi Baba, Mitsuko Nakashima, Moriya Iwaizumi, Satoshi Osawa, et al.


  • Open Access

    Comparison of adenoma detection rate using the novel 5-LED vs xenon-light endoscopic system: Propensity score matching analysis

    by Tatsuhiro Ito, Satoshi Osawa, Takanori Yamada, Keisuke Inagaki, Tomohiiro Takebe, Satoru Takahashi, Shunya Onoue, Kiichi Sugiura, Natsuki Ishida, Tomoharu Matsuura, et al.

    Olympus’s new endoscopic system, EVIS X1, features five-LED illumination and a novel complementary metal-oxide-semiconductor (CMOS) image sensor distinct from conventional charge-coupled devices (CCDs), potentially improving colorectal adenoma detection rates (ADRs). This study compared ADR and related indicators between the EVIS X1 system and the conventional EVIS LUCERA ELITE, a xenon-light system. Of 4,915 colonoscopies performed between September 2020 and April 2023, 814 EVIS X1 and 953 LUCERA cases met inclusion criteria. After propensity score matching to balance baseline characteristics, 660 patients per group were analyzed. Outcomes included ADR, polyp detection rate (PDR), adenomas per colonoscopy (APC), and polyps per colonoscopy (PPC). Subgroup analysis assessed the impact of CMOS-equipped scopes within the X1 group. ADR was slightly higher in the X1 group (36.1%) than the LUCERA group (32.1%), although not statistically significant (P = 0.147). APC (0.77 vs. 0.61, P = 0.034) and PPC (0.95 vs. 0.75, P = 0.023) were significantly higher with X1. Within the X1 group, scopes with CMOS sensors achieved a significantly higher ADR (41.9%) compared with those without. Mean size of polyps detected was smaller with CMOS than with CCD scopes. Multivariate analysis identified age > 60 years, male sex, positive fecal occult blood test, and use of the X1 system with CMOS scopes as independent predictors of higher ADR. The EVIS X1 system may have the potential to improve adenoma detection, particularly when used with CMOS sensor-equipped scopes. These findings suggest potential benefits for colorectal cancer screening, although further large-scale studies are warranted for validation.


  • Open Access

    Ustekinumab effectiveness in Crohn’s disease with lesions in the intestines

    by Satoshi Tamura, Yusuke Asai, Natsuki Ishida, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, et al.

    Ustekinumab is prescribed for the treatment of patients with steroid-resistant moderate to severe Crohn’s disease. We investigated its clinical outcome in patients with small and large intestinal lesions. Patients who were newly administered ustekinumab between March 2014 and December 2020 at Hamamatsu University Hospital were included in the study. The primary endpoint was Crohn’s disease activity index score at baseline and weeks 8, 24, and 48 after the initiation of treatment, and secondary endpoints were albumin, hemoglobin, and C-reactive protein at these time points. Ustekinumab treatment retention was examined in both groups; the 2 groups were compared using the Friedman test, Mann–Whitney U test, or Fisher exact test. Overall, Crohn’s disease activity index scores improved between baseline and 48 weeks, but the difference was not significant. However, there was a significant improvement between baseline and 48 weeks in patients with lesions in the small intestine only. Overall, patients showed significant improvement in albumin levels between baseline and 48 weeks but not in C-reactive protein or hemoglobin levels. When limited to patients with lesions in the small intestine, albumin and hemoglobin levels showed significant improvement. Both types showed high rates of treatment retention, although there was no significant difference. Ustekinumab appears to be a safe and effective treatment option that may be particularly effective in patients with lesions in the small intestine only.


  • Open Access

    Transition of people’s perspectives toward Dianthus spp. in pre-modern literary works

    by Satoshi Osawa

    Based on the analysis of classical literary works, this study elucidated the presence of references to the flower Dianthus spp., the types of emotions associated with it, and the descriptions related to its growth in riparian areas. Keyword extraction from the waka poetry database of the International Research Center for Japanese Studies revealed that D. spp. is mentioned in 444 poems written from the Asuka Period to the Muromachi Period. The most common type of sentiment felt toward this flower was awe in front of its beauty throughout all eras. However, the proportion of lover’s substitutes decreased as time progressed. There were no significant differences in the percentages of emotions between the term “Nadeshiko” and “Yamatonadeshiko”. The term “Kawaranadeshiko” first appeared in 1459 and was used in waka poems to describe the melancholy or sense of impermanence evoked by water flowing away along the riverbank. In contrast, only 57 references to D. spp. have been detected in literary works other than waka poetry anthologies, indicating that D. spp. is mostly associated with waka poetry. Fifteen cases mentioned its growth in riparian areas, which are associated with rivers. This study argues that within the Japanese cultural context, people’s perspectives toward D. spp. developed in two directions as they approached modernity.